Newer phase II trial designs gaining ground.
Benowitz
Steve
S
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D017322:Clinical Trials, Phase II as Topic / Q000379:methods; D015195:Drug Design; D023381:Endpoint Determination / Q000379:methods; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012107:Research Design; D014481:United States
D000970:Antineoplastic Agents